Overview
Whether you arrived from a “Solana vs Injective” query or from PEPS coin pages, this hub aggregates ranks, performance and module-backed signals into one canonical URL.
Quick winners
Full comparison
| Metric | SOL | INJ |
|---|---|---|
| Price | $73.15 | $4.99 |
| Market Cap | $43.82B | $490.41M |
| FDV | — | — |
| Volume 24h | $83.73M | $2.65M |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 7.00 | 99.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +3.74% | +5.97% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | SOL | INJ |
|---|---|---|
| 1H | — | — |
| 24H | +0.54% | +1.03% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | SOL | INJ |
|---|---|---|
| RSI | 39.67 | 49.29 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 2.69 | 0.29 |
| ADX | 12.98 | 12.19 |
| Support | 67.71 | 4.91 |
| Resistance | 78.47 | 5.07 |
| Trend | neutral | neutral |
| Momentum | 72.00 | — |
| Signal | neutral | neutral |
Automatic technical analysis
When RSI and trend disagree across Solana and Injective, expect choppy relative performance until one side reclaims a clear structure.
Fundamentals
| Metric | SOL | INJ |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | 171.00 | 0.00 |
| Github activity | 11,071.00 | 118.00 |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
Solana
Injective
Pros and cons
Pros of Solana
- Market-cap scale on Solana may dampen some idiosyncratic shocks versus smaller peers.
- SOL often anchors narratives that attract sustained media and analyst coverage.
- Higher ranking for Solana can translate into tighter spreads on major venues.
Cons of Solana
- Indicator stacks on Solana may stay stretched longer than expected in strong trends.
- Data gaps in niche fundamentals still apply — absence of a field is not confirmation.
- When dominance narratives fade, Solana can lag hotter rotation names.
- Crowded positioning around SOL sometimes amplifies squeeze or flush risk.
Pros of Injective
- Injective can offer higher relative beta when market attention rotates toward its niche.
- Diversifying versus Solana with Injective can change portfolio factor exposure.
- PEPS tracking for Injective still includes AI score and level context for monitoring.
Cons of Injective
- Incomplete fundamental coverage can hide operational or tokenomic risks.
- Relative underperformance versus Solana can persist through entire market regimes.
- Smaller book depth versus large caps can increase slippage for Injective.
- Higher volatility on INJ cuts both ways and demands stricter risk limits.
Which looks stronger right now?
The “stronger” label here is descriptive, not predictive. Solana and Injective can alternate leadership as macro liquidity and narrative rotate.
AI summary
In about three hundred words of context: Solana (SOL) trades near $73.15 with a +0.54% day move, while Injective (INJ) is around $4.99 (+1.03%). Volume leadership currently sits with Solana, and market-cap leadership with Solana. Technical trend labels read neutral vs neutral, with RSI near 39.67/49.29. Bottom line: use this page as a structured checklist, then open each coin page and related PEPS tools before acting. Nothing here is financial advice.
FAQ
Which is better, Solana or Injective?
“Better” depends on horizon and risk. Solana leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, SOL or INJ?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both Solana and Injective.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. Solana currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.